CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Growing incidence of hearing and nasal disorders
3.4.1.2. Technological advancements
3.4.1.3. Growing geriatric population
3.4.1.4. Increase in patient preference for minimally invasive procedures
3.4.2. Restraints
3.4.2.1. High cost of devices
3.4.2.2. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Lucrative opportunities in the emerging economies
3.4.3.2. High demand for cosmetic ENT procedures
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 ENT & BRONCHOSCOPY DEVICES MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ENDOSCOPES
4.2.1. Rigid endoscopes
4.2.1.1. Otoscopes
4.2.1.2. Sinuscopes
4.2.2. Flexible endoscopes
4.2.2.1. Laryngoscopes
4.2.2.2. Pharyngoscopes
4.2.2.3. Rhinoscopes
4.2.2.4. Nasopharyngoscopes
4.2.3. Hearing screening devices
4.2.4. Bronchoscopes
4.2.5. Key market trends
4.2.6. Key growth factors and opportunities
4.2.7. Market size and forecast
4.3. SURGICAL ENT & BRONCHOSCOPY DEVICES
4.3.1. Powered surgical instruments
4.3.2. Radiofrequency devices
4.3.3. Handheld instruments
4.3.3.1. Rhinology instruments
4.3.3.2. Otology instruments
4.3.3.3. Laryngeal instruments
4.3.3.4. Head and neck surgical instruments
4.3.3.5. Other handheld instruments
4.3.4. Balloon sinus dilation devices
4.3.5. Nasal splints & stents
4.3.6. Bronchial/tracheal stents
4.3.7. Ear tubes
4.3.8. ENT lasers
4.3.9. Image-guided surgery systems
4.3.10. Key market trends
4.3.11. Key growth factors and opportunities
4.3.12. Market size and forecast
4.4. HEARING CARE DEVICES
4.4.1. Hearing aids
4.4.1.1. Behind-the-ear (BTE) aids
4.4.1.2. In-the-ear aids
4.4.1.3. Receiver-in-the-ear (RITE)
4.4.1.4. Canal hearing aids
4.4.2. Hearing implants
4.4.2.1. Cochlear implants
4.4.2.2. Bone-anchored hearing systems (BAHS)
4.4.2.3. Auditory brainstem implants
4.4.2.4. Middle ear implants
4.4.3. Key market trends
4.4.4. Key growth factors and opportunities
4.4.5. Market size and forecast
CHAPTER 5 ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS & CLINICS
5.2.1. Market size and forecast
5.3. HOME-USE
5.3.1. Market size and forecast
5.4. AMBULATORY SURGICAL CENTERS (ASCS)
5.4.1. Market size and forecast
CHAPTER 6 ENT & BRONCHOSCOPY DEVICES MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Rest of Europe
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. South Korea
6.4.8. Australia
6.4.9. Rest of Asia-Pacific
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Saudi Arabia
6.5.7. Rest of LAMEA
CHAPTER 7 COMPANY PROFILES
7.1. COCHLEAR LIMITED
7.1.1. Overview
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. ENTELLUS MEDICAL, INC.
7.2.1. Company overview
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. GN STORE NORD A/S
7.3.1. Overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves and developments
7.4. HOYA CORPORATION (PENTAX MEDICAL)
7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves and developments
7.5. JOHNSON & JOHNSON
7.5.1. Overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves and developments
7.6. KARL STORZ GMBH & CO. KG
7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves and developments
7.7. MED-EL
7.7.1. Overview
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. MEDTRONIC PLC
7.8.1. Company Overview
7.8.2. Operating business segments
7.8.3. Business performance
7.9. OLYMPUS CORPORATION
7.9.1. Company overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves and developments
7.10. SIVANTOS PTE. LTD.
7.10.1. Overview
7.10.2. Business performance
7.10.3. Key strategic moves and developments
7.11. SMITH & NEPHEW PLC.
7.11.1. Company overview
7.11.2. Operating business segments
7.11.3. Business performance
7.12. SONOVA HOLDING AG
7.12.1. Overview
7.12.2. Operating business segments
7.12.3. Business Performance
7.12.4. Key strategic moves and developments
7.13. WILLIAM DEMANT HOLDING A/S
7.13.1. Overview
7.13.2. Operating business segments
7.13.3. Business performance